July 18, 2012Transplant Trialsadmin LEXINGTON, Mass. -- Agenus, Inc. today announced that GlaxoSmithKline's (GSK) herpes zoster vaccine candidate (HZ/su), which contains Agenus' QS-21 Stimulon(R)1 adjuvant as a component of GSK's adjuvant ...
